Trends in prostate cancer incidence and mortality before and after the introduction of PSA testing in the Slovak and Czech Republics

Tumori

Volumn 97, Issue 2, 2011, Pages 149-155

  Ondrusova, Martina ^a   Ondrus, Dalibor ^b   Karabinos, Juraj ^b   Muzik, Jan ^c   Kliment, Jan ^d   Gulis, Gabriel ^e  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c MASARYK UNIVERSITY   (Czech Republic)

^d University Teaching Hospital in Martin   (Slovakia)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Mortality; Prostate cancer incidence; PSA testing

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; CZECH REPUBLIC; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RISK ASSESSMENT; SLOVAKIA; TREND STUDY;

EID: 79957629986     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161109700203     Document Type: Article

References (25)

1. Signorello LB, Adami HO: Prostate Cancer. In: Textbook of Cancer Epidemiology, Adami HO, Hunter D, Trichooulos D (Eds), pp 400-428, Oxford University Press, New York, 2002.
2. Boyle P, Severi G, Giles GG: The epidemiology of prostate cancer. Urol Clin N Am, 30: 209-217, 2003. (Pubitemid 36520595)
3. Garcia M, Jemal A, Ward EM, Center MM, Hao Y, Siegel RL, Thun MJ: Global cancer facts & figures 2007, 46 pp, American Cancer Society, Atlanta, 2007. Available at www.cancer.org
4. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P: Estimates of cancer incidence and mortality in Europe 2006. Ann Oncol, 18: 581-592, 2007.
5. Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, IARC Press, Lyon, 2004.
6. Dusek L, Muzik J, Kubasek M, Koptikova J, Zaloudik J, Vyzula R: Epidemiology of malignant tumours in the Czech Republic [online]. Masaryk University, Brno, 2005. Available at http://www.svod.cz. Version 7.0 [2007].
7. Ondrusova M, Plesko I, Safaei-Diba Ch, Obsitnikova, A, Stefanakova D, Ondrus D: Comprehensive analysis of incidence and mortality of malignant tumours in the Slovak Republic. [online]. National Cancer Registry of the Slovak Republic, NHIC; Bratislava, 2007. Available at http://www.nor-sk.org/
8. Safaei-Diba Ch, Plesko I, Obsitnikova A, Dienerova M, Kalmancokova A, Kopecka I, Ondrusova M, Piestanska G, Valentikova K, Wieningerova D: Cancer incidence in the Slovak Republic 2005. NCR SR, NHIC; Bratislava, 2009.
9. Curado MP, Edwards B, Shin HR, Ferlay J, Heanue M, Boyle P, Storm H (Eds): Cancer Incidence in Five Continents, Vol IX, IARC Scient Publ No. 160, IARC; Lyon, 2007.
10. American Cancer Society: Cancer Facts & Figures 2003, 48 pp, American Cancer Society, Atlanta, 2003. Available at www.cancer.org
11. Aareleid T: Central and Eastern Europe. In: IARC Newsletter No. 33, Whelan SL (Ed), Dec 19-20, 2003. Available at www.iarc.fr
12. Baade P, Youlden DR, Krnjacki LJ: International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res, 53: 171-184, 2009.
13. Haas GP, Delongchamps N, Brawley OW, Wang CI, de la Roza G: The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol, 15: 3866-3871, 2008.
14. Kausitz J: Possibilities in using radioimmunoassay of tumor markers in diagnosis of carcinomas of the testes and prostate. Bratisl Med J, 89: 715-724, 1988 (in Slovak).
15. Kliment J, Ondrusova M, Abrahamova J, Babjuk M, Ondrus D, Muzik J, Dusek L: Epidemiology of malignant tumors of prostate - comparison of the population of the CR and SR. Ces Urol, 13: 79-103, 2009 (in Slovak).
16. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds): SEER Cancer Statistics Review, 1975-2006, NCI, Bethesda, 2009. Available at http://seer.cancer.gov/csr/1975-2006/
17. Levi F, Lucchini F, Negri E, Boyle P, LaVecchia C: Leveling of prostate cancer mortality in Western Europe. Prostate, 60: 46-52, 2004. (Pubitemid 38669228)
18. Quinn M, Babb P: Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparison. BJU Int, 90: 162-173, 2002.
19. La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, Levi F: Cancermortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol, 21: 1323-1360, 2010.
20. Levi F, Lucchini F, Negri E, La Vecchia C: Trends in mortality from major cancers in the European Union, including acceding countries, in 2004. Cancer, 101: 2843-2860, 2004.
21. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL,Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G,Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD, PLCO Project Team: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med, 360: 1310-1319, 2009.
22. Hussain S, Gunnell D, Donovan J, McPhail S, Hamdy F, Neal D, Albertsen P, Verne J, Stephens P, Trotter C, Martin RM: Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004. BJU Int, 101: 547-555, 2008.
23. World Health Organization: The World Health Report 2004 - Changing History.WHO, Geneva, 2004.
24. Hsing AW, Tsao L, Devesa SS: International trends and patterns of prostate cancer incidence andmortality. Int J Cancer, 85: 60-67, 2000.
25. Crawford ED: Epidemiology of prostate cancer. Urology, 62: Suppl. 6A, 3-12, 2003.